Studies of gene fusions in rhabdomyosarcoma
Studies of gene fusions in rhabdomyosarcoma
批准号:
8349513
负责人:
Frederic Barr
金额:
$17.03万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
4-Hydroxy-TamoxifenAlveolarAlveolar RhabdomyosarcomaAttenuatedBMI1 geneCellsChimeric ProteinsEnvironmentEstrogen ReceptorsGene FusionGoalsGrowthHumanLaboratoriesLigand Binding DomainMYCN geneMalignant NeoplasmsMediatingMolecularMyoblastsNational Cancer InstituteOncogene ProteinsOncogenicPAX3 genePennsylvaniaPhenotypeProteinsRecurrenceResearch PersonnelRhabdomyosarcomaSystemTherapeuticTimeToxic effectUniversitiescell typecellular transductioninterestresearch studytumorigenesistumorigenic
中文摘要
高级研究员在2011财年转移到国家癌症研究所,并在剩下的时间里建立了实验室。因此,2011财年未对该项目进行任何研究。然而,在宾夕法尼亚大学以前的研究中,高级研究员做出了以下观察。我们利用人肌生成系统研究了PAX3-FOXO1在与肺泡横纹肌肉瘤(ARMS)更相关的细胞环境中的融合。从用BMI1和TERT永生化的人成肌细胞系开始,用PAX3-FOXO1和MYCN转导导致转化和致瘤活性。绝大多数转导细胞表达低PAX3-FOXO1水平,不具有转化或致瘤表型。相比之下,只有少数转导的细胞表达高水平的PAX3-FOXO1,并且转化和致瘤。这些发现与PAX3-FOXO1高表达的毒性和细胞自主变化的发生一致,这些变化允许罕见细胞规避高表达的毒性作用。为了在一个更动态的系统中研究表型与融合蛋白水平之间的关系,我们开发了一个4-羟基他莫昔芬诱导的系统,其中PAX3-FOXO1连接到修饰的雌激素受体配体结合域。使用MYCN转导的成肌细胞和这种诱导结构,我们发现PAX3-FOXO1诱导导致转化和致瘤活性,但也导致生长抑制增加。因此,该诱导体系对pax3 - foxo1诱导毒性机制的研究具有重要意义。
英文摘要
The Senior Investigator moved to the National Cancer Institute during FY2011 and has been setting up the laboratory during the remaining time. Therefore no research studies were performed on this project during FY2011. However, in previous studies at the University of Pennsylvania, the Senior Investigator made the following observations. We have utilized a human myogenic system to study the PAX3-FOXO1 fusion in a cellular environment more relevant to alveolar rhabodmyosarcoma (ARMS). Starting with a human myoblast line immortalized with BMI1 and TERT, transduction with PAX3-FOXO1 and MYCN resulted in transforming and tumorigenic activities. The far majority of transduced cells expressed low PAX3-FOXO1 levels and did not have a transformed or tumorigenic phenotype. In contrast, only a small number of transduced cells expressed high PAX3-FOXO1 levels, and were transformed and tumorigenic. These findings are consistent with the toxicity of high PAX3-FOXO1 expression and the occurrence of cell autonomous changes allowing rare cells to circumvent the toxic effects of high-level expression. To investigate the relationship between phenotype and fusion protein level in a more dynamic system, we developed a 4-hydroxytamoxifen inducible system in which PAX3-FOXO1 is joined to a modified estrogen receptor ligand-binding domain. Using myoblasts transduced with MYCN and this inducible construct, we found that PAX3-FOXO1 induction results in transforming and tumorigenic activities, but also causes increasing growth suppression. Therefore, the inducible system will be useful for our studies of the mechanism of PAX3-FOXO1-induced toxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies of gene fusions in rhabdomyosarcoma
-
批准号:10486830
-
项目类别:
-
资助金额:$70.45万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Studies of amplification in rhabdomyosarcoma
-
批准号:8349507
-
项目类别:
-
资助金额:$17.03万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Studies of amplification in rhabdomyosarcoma
-
批准号:8763479
-
项目类别:
-
资助金额:$33.5万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Clinical Operations for Laboratory of Pathology
-
批准号:9556867
-
项目类别:
-
资助金额:$66.83万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Studies of gene fusions in rhabdomyosarcoma
-
批准号:9153887
-
项目类别:
-
资助金额:$47.33万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Studies of gene fusions in rhabdomyosarcoma
-
批准号:8763485
-
项目类别:
-
资助金额:$40.2万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Studies of amplification in rhabdomyosarcoma
-
批准号:9556544
-
项目类别:
-
资助金额:$30.47万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Epigenetic studies in rhabdomyosarcoma
-
批准号:9153908
-
项目类别:
-
资助金额:$43.38万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Epigenetic studies in rhabdomyosarcoma
-
批准号:8553174
-
项目类别:
-
资助金额:$51.06万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Epigenetic studies in rhabdomyosarcoma
-
批准号:8938110
-
项目类别:
-
资助金额:$50.65万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Studies of amplification in rhabdomyosarcoma
-
批准号:8938081
-
项目类别:
-
资助金额:$41.07万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Studies of gene fusions in rhabdomyosarcoma
-
批准号:9343899
-
项目类别:
-
资助金额:$59.23万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Anatomic Pathology Residency Program
-
批准号:9556893
-
项目类别:
-
资助金额:$152.37万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Anatomic Pathology Residency Program
-
批准号:10703126
-
项目类别:
-
资助金额:$203.96万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Studies of amplification in rhabdomyosarcoma
-
批准号:10926196
-
项目类别:
-
资助金额:$74.45万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Epigenetic studies in rhabdomyosarcoma
-
批准号:10014672
-
项目类别:
-
资助金额:$30.76万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Studies of amplification in rhabdomyosarcoma
-
批准号:9343894
-
项目类别:
-
资助金额:$29.61万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Studies of amplification in rhabdomyosarcoma
-
批准号:10486826
-
项目类别:
-
资助金额:$54.79万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Epigenetic studies in rhabdomyosarcoma
-
批准号:10486842
-
项目类别:
-
资助金额:$39.14万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
Histology Core Laboratory
-
批准号:9556801
-
项目类别:
-
资助金额:$187.13万
-
财政年份:--
-
负责人:Frederic Barr
-
依托单位:
海外基金